menu
    • menu

    Company profile for Plexium

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Plexium is the premier, next-generation targeted protein degradation (TPD) company. We lead the way in the rational design and discovery of monovalent protein degraders across a wide range of modalities. Plexium's best-in-class platform propels us toward the discovery of next-generation TPD drugs that extend beyond the limited applications of Proteolysis Targeting Chimeras (PROTACs) and cereblon imids, unravelling the boundles...
    Plexium is the premier, next-generation targeted protein degradation (TPD) company. We lead the way in the rational design and discovery of monovalent protein degraders across a wide range of modalities. Plexium's best-in-class platform propels us toward the discovery of next-generation TPD drugs that extend beyond the limited applications of Proteolysis Targeting Chimeras (PROTACs) and cereblon imids, unravelling the boundless possibilities of true drug-like protein degraders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PlexiumUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    11494 Sorrento Valley Road San Diego CA 92121
    Telephone
    Telephone
    +1 858-290-4510
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.plexium.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AbbVie-Partnered Protein Degrader Specialist Plexium raises $60M
    AbbVie-Partnered Protein Degrader Specialist Plexium raises $60M

    29 Aug 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/months-after-layoffs-abbvie-partnered-protein-degrader-specialist-plexium-raises-60m

    FIERCE BIOTECH
    29 Aug 2025
    Share Share
    Plexium Cuts Staff, Realigns Resources to Support Pipeline
    Plexium Cuts Staff, Realigns Resources to Support Pipeline

    03 Jun 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/plexium-cuts-staff-realigns-resources-support-protein-degrader-pipeline

    FIERCE BIOTECH
    03 Jun 2025
    Share Share
    Plexium to Present Selective Degrader Programs at AACR 2025
    Plexium to Present Selective Degrader Programs at AACR 2025

    28 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/plexium-announces-multiple-presentations-at-aacr-2025-with-selective-monovalent-degrader-programs-targeting-smarca2-ikzf2-and-cdk2-302440158.html

    PR NEWSWIRE
    28 Apr 2025
    Share Share
    Plexium Appoints Jorge F. DiMartino as Chief Medical Officer
    Plexium Appoints Jorge F. DiMartino as Chief Medical Officer

    01 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/plexium-announces-appointment-of-jorge-f-dimartino-md-phd-as-chief-medical-officer-302263901.html

    PR NEWSWIRE
    01 Oct 2024
    Share Share
    Plexium Initiates Dosing in Phase 1 Study of PLX-4545
    Plexium Initiates Dosing in Phase 1 Study of PLX-4545

    12 Dec 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/plexium-initiates-dosing-in-phase-1-study-of-plx-4545-a-potent-and-selective-degrader-of-the-transcription-factor-ikzf2-302012336.html

    PR NEWSWIRE
    12 Dec 2023
    Share Share
    PLEXIUM APPOINTS BRIAN WONG, M.D., PH.D., TO ITS BOARD OF DIRECTORS
    PLEXIUM APPOINTS BRIAN WONG, M.D., PH.D., TO ITS BOARD OF DIRECTORS

    13 Jul 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/plexium-appoints-brian-wong-md-phd-to-its-board-of-directors-301585742.html

    PRNEWSWIRE
    13 Jul 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search